<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">RUDN Journal of Medicine</journal-id><journal-title-group><journal-title xml:lang="en">RUDN Journal of Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российского университета дружбы народов. Серия: Медицина</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2313-0245</issn><issn publication-format="electronic">2313-0261</issn><publisher><publisher-name xml:lang="en">Peoples’ Friendship University of Russia named after Patrice Lumumba (RUDN University)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3200</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">HE CHARACTERISTICS OF GENETIC POLYMORPHISM OF HLA-ANTIGENS IN ACQUIRED APLASTIC ANEMIA IN CHILDREN</article-title><trans-title-group xml:lang="ru"><trans-title>Особенности генетического полиморфизма HLA-антигенов при приобретенной апластической анемии у детей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Chumak</surname><given-names>A A</given-names></name><name xml:lang="ru"><surname>Чумак</surname><given-names>Анна Александровна</given-names></name></name-alternatives><bio xml:lang="en">Department of Health of the City of Moscow HLA-typing laboratory</bio><bio xml:lang="ru">Лаборатория HLA-типирования</bio><email>crlpv@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Astrelina</surname><given-names>T A</given-names></name><name xml:lang="ru"><surname>Астрелина</surname><given-names>Татьяна Алексеевна</given-names></name></name-alternatives><bio xml:lang="en">Department of Health of the City of Moscow HLA-typing laboratory</bio><email>t_astrelina@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Yakovleva</surname><given-names>M V</given-names></name><name xml:lang="ru"><surname>Яковлева</surname><given-names>Мария Валерьевна</given-names></name></name-alternatives><bio xml:lang="en">Department of Health of the City of Moscow HLA-typing laboratory</bio><email>crlpv@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Lebedeva</surname><given-names>Lidiya L'vovna</given-names></name><name xml:lang="ru"><surname>Лебедева</surname><given-names>Лидия Львовна</given-names></name></name-alternatives><bio xml:lang="en">Department of Health of the City of Moscow HLA-typing laboratory</bio><email>crlpv@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>TV Pukhlikova</surname><given-names>L L</given-names></name><name xml:lang="ru"><surname>Пухликова</surname><given-names>Татьяна Владимировна</given-names></name></name-alternatives><bio xml:lang="en">Department of Health of the City of Moscow HLA-typing laboratory</bio><email>crlpv@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dishlevaya</surname><given-names>Z M</given-names></name><name xml:lang="ru"><surname>Дышлевая</surname><given-names>Зарема Михайловна</given-names></name></name-alternatives><bio xml:lang="en">Department of Hematology № 1</bio><bio xml:lang="ru">Отделение гематологии</bio><email>dishleva@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Arkhipova</surname><given-names>A N</given-names></name><name xml:lang="ru"><surname>Архипова</surname><given-names>Анастасия Николаевна</given-names></name></name-alternatives><bio xml:lang="en">Department of Hematology № 1</bio><bio xml:lang="ru">Отделение гематологии</bio><email>tan.120505@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Azova</surname><given-names>M M</given-names></name><name xml:lang="ru"><surname>Азова</surname><given-names>Мадина Мухамедовна</given-names></name></name-alternatives><bio xml:lang="en">Department of Biology and General Genetics</bio><bio xml:lang="ru">Кафедра биологии и общей генетики</bio><email>azovam@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">GBUZ “Stem cell bank”</institution></aff><aff><institution xml:lang="ru">ГБУЗ «Банк стволовых клеток Департамента Здравоохранения города Москвы»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">FSBI RCCH Health Ministry of Russia</institution></aff><aff><institution xml:lang="ru">ФГБУ РДКБ Минздравсоцразвития России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Peoples’ Friendship University of Russia</institution></aff><aff><institution xml:lang="ru">Российский университет дружбы народов</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2013-01-15" publication-format="electronic"><day>15</day><month>01</month><year>2013</year></pub-date><issue>1</issue><issue-title xml:lang="en">NO1 (2013)</issue-title><issue-title xml:lang="ru">№1 (2013)</issue-title><fpage>15</fpage><lpage>19</lpage><history><date date-type="received" iso-8601-date="2016-09-07"><day>07</day><month>09</month><year>2016</year></date></history><permissions><copyright-statement xml:lang="ru">Copyright ©; 2013, Чумак А.А., Астрелина Т.А., Яковлева М.В., Лебедева Л.Л., Пухликова Т.В., Дышлевая З.М., Архипова А.Н., Азова М.М.</copyright-statement><copyright-year>2013</copyright-year><copyright-holder xml:lang="ru">Чумак А.А., Астрелина Т.А., Яковлева М.В., Лебедева Л.Л., Пухликова Т.В., Дышлевая З.М., Архипова А.Н., Азова М.М.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.rudn.ru/medicine/article/view/3200">https://journals.rudn.ru/medicine/article/view/3200</self-uri><abstract xml:lang="en">This study presents the genetic polymorphism of HLA-antigens in acquired aplastic anemia (AAA) in 147 children (85 boys и 62 girls) aged 1 to 18 with. The control group is consisted of 1700 umbilical cord blood samples of healthy newborns. The genetic polymorphism of HLA was studied in groups of children with AAA, divided by gender and age. Our results revealed distinction in HLA-markers of predisposition and sustainability to AAA. Possible differences in factors of immunogenetic predisposition suggest different mechanisms involved in the development of the disease in different groups of children and reconsider the existing model of the pathogenesis of AAA.</abstract><trans-abstract xml:lang="ru">В статье представлены результаты исследования генетического полиморфизма HLA-антигенов при приобретенной апластической анемии (ПАА) у 147 детей в возрасте от 1 до 18 лет. Контрольная группа была представлена 1700 образцами пуповинной крови условно здоровых новорожденных детей. Анализ полученных данных позволил выявить отличающиеся у детей разного пола и возраста HLA-маркеры предрасположенности и протекции к ПАА. Вероятное различие в факторах иммуногенетической предрасположенности позволяет предположить участие разных механизмов в развитии заболевания у разных групп детей и по-новому рассматривать уже имеющиеся модели патогенеза ПАА.</trans-abstract><kwd-group xml:lang="en"><kwd>HLA-antigens</kwd><kwd>acquired aplastic anemia</kwd><kwd>children</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>антигены HLA-системы</kwd><kwd>приобретенная апластическая анемия</kwd><kwd>дети</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Young N. S., Kaufman D.W. The epidemiology of acquired aplastic anemia // Haematologica. — 2008. — Vol. 93. — P.489.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Albert E., Thomas E.D., Nisperos B. et al. HLA antigens and haplotypes in 200 patients with aplastic anemia // Transplantation. — 1976. — Vol. 22. — P. 528—531.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Dausset J., Svejgaard A. HLA and Disease. — Copenhagen: Munksgaard, 1977. — P. 84—93.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Chapuis B., Von Fliedner V.E., Jeannet M. et al. Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parents // Br J Haematol. — 1986. — Vol. 63(1). — P. 51—57.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Капустин С.И. Особенности аллельного полиморфизма генов HLA II класса в здоровой популяции Санкт-Петербурга и у больных тяжелой апластической анемией: Дисс.. канд. биол. наук. — СПб., 1998.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Nakao S., Takamatsu H., Chuhjo T. et al. Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia // Blood. — 1994. — Vol. 84(12). — P. 4257—4261.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Saunthararajah Y., Nakamura R., Nam J.M. et al. HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome // Blood. — 2002. — Vol. 100. — P. 1570—1574.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Dhaliwal J.S., Wong L., Kamaluddin M.A. et al. Susceptibility to aplastic anemia is associated with HLA-DRB1*1501 in an aboriginal population in Sabah, Malaysia // Hum Immunol. — 2011. — Vol. 72(10). — P. 889—892.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Лебедева Л.Л. Генетический полиморфизм антигенов гистосовместимости здорового детского населения Московского региона и при острых лейкозах у детей: Дисс.. канд. биол. наук. — М., 2010.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study // Blood. — 1987. — Vol. 70(6). — P. 1718—1721.</mixed-citation></ref></ref-list></back></article>
